https://innovate.research.ufl.edu/tearclear-completion-pre-ind-fda/
TearClear Announces Successful Completion of Pre-IND Meeting With the FDA for a Preservative Free...
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, announced successful completion of...
https://innovate.research.ufl.edu/tearclear-new-ind-clinical-trial/
TearClear Files Investigational New Drug (IND) Application To Begin Its Clinical Trial for TC-002...
UF startup and UF Innovate | Sid Martin Biotech company TearClear, a late clinical-stage ophthalmic pharmaceutical company, has filed an Investigational New...